Eiken Chemical Sustainability Profile
Eiken Chemical Co., Ltd., commonly referred to as Eiken, is a prominent player in the biotechnology and diagnostics industry, headquartered in Japan. Established in 1950, the company has made significant strides in the development of innovative diagnostic products and laboratory reagents, catering to both domestic and international markets. Eiken's core offerings include a wide range of microbiological testing kits and molecular diagnostics, which are distinguished by their accuracy and reliability. The company has achieved notable milestones, including advancements in rapid testing technologies that enhance patient care and streamline laboratory processes. With a strong market position, Eiken continues to be recognised for its commitment to quality and innovation, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Eiken Chemical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eiken Chemical's score of 50 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eiken Chemical's reported carbon emissions
In 2023, Eiken Chemical Co., Ltd. reported total greenhouse gas emissions of approximately 19,450,000 kg CO2e for Scope 1 and 2, with Scope 1 emissions at about 1,945,000 kg CO2e and Scope 2 emissions at approximately 2,669,000 kg CO2e. The company did not disclose Scope 3 emissions for this year. Eiken Chemical has set ambitious reduction targets, committing to a 56% reduction in absolute Scope 1 and 2 emissions by FY2030 from a FY2021 baseline. Additionally, the company aims to reduce its absolute Scope 3 emissions by 25% by FY2030 from a FY2022 baseline. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support the global goal of limiting temperature rise to 1.5°C. In 2022, Eiken Chemical's total emissions were approximately 20,160,000 kg CO2e for Scope 1 and 2, with Scope 1 at about 2,016,000 kg CO2e and Scope 2 at approximately 5,304,000 kg CO2e, alongside Scope 3 emissions of about 105,334,000 kg CO2e. The company has shown a commitment to reducing its carbon footprint and enhancing sustainability practices within the healthcare equipment and supplies sector. Eiken Chemical's climate commitments reflect a proactive approach to addressing climate change and reducing greenhouse gas emissions across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 1,934,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 4,884,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 000,000,000 | 00,000,000 |
How Carbon Intensive is Eiken Chemical's Industry?
How Carbon Intensive is Eiken Chemical's Location?
Eiken Chemical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eiken Chemical has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Siemens Healthineers AG
Frequently Asked Questions
Common questions about Eiken Chemical's sustainability data and climate commitments